End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
71.2 TWD | 0.00% | -1.79% | -14.93% |
Business Summary
Number of employees: 172
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neuromuscular System Medication
22.5
%
| 117 | 23.6 % | 136 | 22.5 % | +16.75% |
Other Formulations
13.3
%
| 64 | 13.0 % | 81 | 13.3 % | +25.97% |
Anti-inflammatory, Analgesic and Anti-allergic
11.9
%
| 60 | 12.1 % | 72 | 11.9 % | +20.57% |
Gastrointestinal Tract Hepatobiliary System
11.6
%
| 57 | 11.5 % | 71 | 11.6 % | +24.23% |
Cardiovascular Drug
11.5
%
| 52 | 10.5 % | 69 | 11.5 % | +33.56% |
Respiratory Tract Medications
8.2
%
| 32 | 6.5 % | 50 | 8.2 % | +55.57% |
Endocrine System Medicine
6.9
%
| 39 | 7.8 % | 42 | 6.9 % | +8.78% |
Urinary System Medications
5.7
%
| 29 | 5.9 % | 35 | 5.7 % | +17.83% |
Vitamins and Minerals
5.0
%
| 27 | 5.5 % | 30 | 5.0 % | +11.18% |
Chemotherapeutic Agents
3.4
%
| 18 | 3.6 % | 21 | 3.4 % | +15.65% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
99.8
%
| 494 | 99.9 % | 605 | 99.8 % | +22.47% |
Asia
0.2
%
| 0 | 0.1 % | 1 | 0.2 % | +310.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pai Hsiung Huang
CEO | Chief Executive Officer | - | 92-03-13 |
I Hsiu Chen
DFI | Director of Finance/CFO | - | - |
Pai Shou Huang
BRD | Director/Board Member | - | 13-05-23 |
Kuo An Liao
BRD | Director/Board Member | - | 95-03-29 |
Chun Wei Lin
IRC | Investor Relations Contact | - | 10-10-31 |
I Tsung Chiu
PRN | Corporate Officer/Principal | - | 12-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pai Hsiung Huang
CEO | Chief Executive Officer | - | 92-03-13 |
Pai Hsun Huang
BRD | Director/Board Member | - | 07-01-01 |
Kuo An Liao
BRD | Director/Board Member | - | 95-03-29 |
Ching Chuan Liao
BRD | Director/Board Member | - | - |
Pai Shou Huang
BRD | Director/Board Member | - | 13-05-23 |
Hsi Hung Yang
BRD | Director/Board Member | - | - |
Chih Heng Li
BRD | Director/Board Member | - | 12-10-10 |
Tsung Cheng Lai
BRD | Director/Board Member | 73 | 12-10-10 |
Tsun Che Huang
BRD | Director/Board Member | - | - |
Li Ling Yang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,929,075 | 31,135,075 ( 69.30 %) | 0 | 69.30 % |
Company contact information
Johnson Chemical Pharmaceutical Works Co., Ltd.
No. 77, 79, Section 4, Sanhe Road Sanchung District
241 51, New Taipei City
+
http://www.jcpjohnson.com.twSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-14.93% | 98.53M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 4747 Stock
- Company Johnson Chemical Pharmaceutical Works Co., Ltd.